What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year [Yahoo! Finance]
Haemonetics (HAE) had its price target lowered by Citigroup Inc. from $75.00 to $70.00. They now have a "neutral" rating on the stock.
Here's Why Haemonetics (HAE) is a Strong Value Stock [Yahoo! Finance]
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference